hoge/4615
更新日: 2015-10-29 (木) 06:59:14 (3102d)
Directory enquiries <a href=" http://www.cir-integracion-racial-cuba.org/liquid-ibuprofen-dosage-for-dogs.pptx ">pediatric ibuprofen dosage by weight</a> I am glad that HP reveals its 2014 and 2015 projections. It claims to earn in excessive of http://www.kazuwaya.jp/clubskin/?cmd=secedit&page=hoge%2F4615&id=1&level=true.6/share from this point on ( 2014 and beyond); yet, the stock is trading around $22/share thanks to those joker âanalystsâ comment and their âprice targetâ. These analysts from âMizuho, Evercore, Goldman Sachs, UBS, Needham, Piper Jaffray, Raymond James, Wells Fargo, â¦â set their target at $22 or below is just do not make any sense. For a company with revenue over $110B/year, and earning http://www.kazuwaya.jp/clubskin/?cmd=secedit&page=hoge%2F4615&id=1&level=true.6/share and higher for the next 3 years, that is about 5.5x PE (price to earning ratio), there is no other investment in S&P 500 better than HP. Are these analysts miscalculated their thoughts, or bias? If so, why are we listening to them and why are you quoting these estimations? Please stop quoting them or to spread out false information ( from these analysts) because these information you are spreading out do not make sense. To me a price target in the neighborhood of http://www.kazuwaya.jp/clubskin/?cmd=secedit&page=hoge%2F4615&id=1&level=true5 ( PE=10) is reasonable, do you agree? 
メッセージ
Directory enquiries <a href=" http://www.cir-integracion-racial-cuba.org/liquid-ibuprofen-dosage-for-dogs.pptx ">pediatric ibuprofen dosage by weight</a> I am glad that HP reveals its 2014 and 2015 projections. It claims to earn in excessive of $3.6/share from this point on ( 2014 and beyond); yet, the stock is trading around $22/share thanks to those joker âanalystsâ comment and their âprice targetâ. These analysts from âMizuho, Evercore, Goldman Sachs, UBS, Needham, Piper Jaffray, Raymond James, Wells Fargo, â¦â set their target at $22 or below is just do not make any sense. For a company with revenue over $110B/year, and earning $3.6/share and higher for the next 3 years, that is about 5.5x PE (price to earning ratio), there is no other investment in S&P 500 better than HP. Are these analysts miscalculated their thoughts, or bias? If so, why are we listening to them and why are you quoting these estimations? Please stop quoting them or to spread out false information ( from these analysts) because these information you are spreading out do not make sense. To me a price target in the neighborhood of $35 ( PE=10) is reasonable, do you agree?
- このページを共有：
-
このページのURL：
